The store will not work correctly when cookies are disabled.
1-[(3-naphthalen-2-yl)-(1,2,4-triazol-4-yl)]-3-phenol
ID: ALA379717
PubChem CID: 11666402
Max Phase: Preclinical
Molecular Formula: C18H13N3O
Molecular Weight: 287.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Oc1cccc(-n2cnnc2-c2ccc3ccccc3c2)c1
Standard InChI: InChI=1S/C18H13N3O/c22-17-7-3-6-16(11-17)21-12-19-20-18(21)15-9-8-13-4-1-2-5-14(13)10-15/h1-12,22H
Standard InChI Key: VVFHMZNOUZIYLJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
-4.4990 -12.5167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8296 -12.0245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0926 -11.2383 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9218 -11.2450 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1722 -12.0354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1121 -12.4206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0971 -13.2465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3755 -13.6448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6683 -13.2182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6873 -12.3892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4095 -11.9946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4954 -13.3384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2088 -13.7551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2037 -14.5793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4859 -14.9879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7719 -14.5662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7805 -13.7434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0532 -14.9714 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9826 -11.9602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2588 -12.3559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9453 -13.6156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2397 -13.1881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 6 1 0
2 6 1 0
2 3 2 0
12 13 2 0
6 7 2 0
13 14 1 0
1 2 1 0
14 15 2 0
7 8 1 0
15 16 1 0
3 4 1 0
16 17 2 0
17 12 1 0
1 12 1 0
8 9 2 0
16 18 1 0
4 5 2 0
10 19 1 0
9 10 1 0
19 20 2 0
5 1 1 0
9 21 1 0
10 11 2 0
21 22 2 0
20 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 287.32 | Molecular Weight (Monoisotopic): 287.1059 | AlogP: 3.79 | #Rotatable Bonds: 2 |
Polar Surface Area: 50.94 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.02 | CX Basic pKa: 1.73 | CX LogP: 3.49 | CX LogD: 3.49 |
Aromatic Rings: 4 | Heavy Atoms: 22 | QED Weighted: 0.61 | Np Likeness Score: -1.04 |
References
1. Zhang Q, Keenan SM, Peng Y, Nair AC, Yu SJ, Howells RD, Welsh WJ.. (2006) Discovery of novel triazole-based opioid receptor antagonists., 49 (14): [PMID:16821764] [10.1021/jm0601250] |